152 related articles for article (PubMed ID: 38135585)
1. Hereditary papillary renal cell carcinoma.
Jacoba IM; Lu Z
Semin Diagn Pathol; 2024 Jan; 41(1):28-31. PubMed ID: 38135585
[TBL] [Abstract][Full Text] [Related]
2. Clear cell and papillary renal cell carcinomas in hereditary papillary renal cell carcinoma (HPRCC) syndrome: a case report.
Ferlicot S; Just PA; Compérat E; Rouleau E; Tissier F; Vaessen C; Richard S
Diagn Pathol; 2021 Nov; 16(1):107. PubMed ID: 34801057
[TBL] [Abstract][Full Text] [Related]
3. Novel germline c-MET mutation in a family with hereditary papillary renal carcinoma.
Wadt KA; Gerdes AM; Hansen TV; Toft BG; Friis-Hansen L; Andersen MK
Fam Cancer; 2012 Sep; 11(3):535-7. PubMed ID: 22717761
[TBL] [Abstract][Full Text] [Related]
4. Novel mutations of the MET proto-oncogene in papillary renal carcinomas.
Schmidt L; Junker K; Nakaigawa N; Kinjerski T; Weirich G; Miller M; Lubensky I; Neumann HP; Brauch H; Decker J; Vocke C; Brown JA; Jenkins R; Richard S; Bergerheim U; Gerrard B; Dean M; Linehan WM; Zbar B
Oncogene; 1999 Apr; 18(14):2343-50. PubMed ID: 10327054
[TBL] [Abstract][Full Text] [Related]
5. Novel mutation in the ATP-binding site of the MET oncogene tyrosine kinase in a HPRCC family.
Olivero M; Valente G; Bardelli A; Longati P; Ferrero N; Cracco C; Terrone C; Rocca-Rossetti S; Comoglio PM; Di Renzo MF
Int J Cancer; 1999 Aug; 82(5):640-3. PubMed ID: 10417759
[TBL] [Abstract][Full Text] [Related]
6. MET alterations in biphasic squamoid alveolar papillary renal cell carcinomas and clinicopathological features.
Denize T; Just PA; Sibony M; Blons H; Timsit MO; Drossart T; Jakubowicz D; Broudin C; Morini A; Molina T; Vano Y; Auvray-Kuentz M; Richard S; Mejean A; Gimenez Roqueplo AP; Burnichon N; Verkarre V
Mod Pathol; 2021 Mar; 34(3):647-659. PubMed ID: 32770124
[TBL] [Abstract][Full Text] [Related]
7. Novel germline MET pathogenic variants in French patients with papillary renal cell carcinomas type I.
Sebai M; Tulasne D; Caputo SM; Verkarre V; Fernandes M; Guérin C; Reinhart F; Adams S; Maugard C; Caron O; Guillaud-Bataille M; Berthet P; Bignon YJ; Bressac-de Paillerets B; Burnichon N; Chiesa J; Giraud S; Lejeune S; Limacher JM; de Pauw A; Stoppa-Lyonnet D; Zattara-Cannoni H; Deveaux S; Lidereau R; Richard S; Rouleau E
Hum Mutat; 2022 Mar; 43(3):316-327. PubMed ID: 34882875
[TBL] [Abstract][Full Text] [Related]
8. Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype.
Lubensky IA; Schmidt L; Zhuang Z; Weirich G; Pack S; Zambrano N; Walther MM; Choyke P; Linehan WM; Zbar B
Am J Pathol; 1999 Aug; 155(2):517-26. PubMed ID: 10433944
[TBL] [Abstract][Full Text] [Related]
9. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas.
Schmidt L; Duh FM; Chen F; Kishida T; Glenn G; Choyke P; Scherer SW; Zhuang Z; Lubensky I; Dean M; Allikmets R; Chidambaram A; Bergerheim UR; Feltis JT; Casadevall C; Zamarron A; Bernues M; Richard S; Lips CJ; Walther MM; Tsui LC; Geil L; Orcutt ML; Stackhouse T; Lipan J; Slife L; Brauch H; Decker J; Niehans G; Hughson MD; Moch H; Storkel S; Lerman MI; Linehan WM; Zbar B
Nat Genet; 1997 May; 16(1):68-73. PubMed ID: 9140397
[TBL] [Abstract][Full Text] [Related]
10. Papillary renal cell carcinoma: analysis of germline mutations in the MET proto-oncogene in a clinic-based population.
Lindor NM; Dechet CB; Greene MH; Jenkins RB; Zincke MT; Weaver AL; Wilson M; Zincke H; Liu W
Genet Test; 2001; 5(2):101-6. PubMed ID: 11551094
[TBL] [Abstract][Full Text] [Related]
11. Germline and somatic c-met mutations in multifocal/bilateral and sporadic papillary renal carcinomas of selected patients.
Salvi A; Marchina E; Benetti A; Grigolato P; De Petro G; Barlati S
Int J Oncol; 2008 Aug; 33(2):271-6. PubMed ID: 18636147
[TBL] [Abstract][Full Text] [Related]
12. Early onset hereditary papillary renal carcinoma: germline missense mutations in the tyrosine kinase domain of the met proto-oncogene.
Schmidt LS; Nickerson ML; Angeloni D; Glenn GM; Walther MM; Albert PS; Warren MB; Choyke PL; Torres-Cabala CA; Merino MJ; Brunet J; Bérez V; Borràs J; Sesia G; Middelton L; Phillips JL; Stolle C; Zbar B; Pautler SE; Linehan WM
J Urol; 2004 Oct; 172(4 Pt 1):1256-61. PubMed ID: 15371818
[TBL] [Abstract][Full Text] [Related]
13. Duplication and overexpression of the mutant allele of the MET proto-oncogene in multiple hereditary papillary renal cell tumours.
Fischer J; Palmedo G; von Knobloch R; Bugert P; Prayer-Galetti T; Pagano F; Kovacs G
Oncogene; 1998 Aug; 17(6):733-9. PubMed ID: 9715275
[TBL] [Abstract][Full Text] [Related]
14. The genetic basis of cancer of the kidney.
Linehan WM; Walther MM; Zbar B
J Urol; 2003 Dec; 170(6 Pt 1):2163-72. PubMed ID: 14634372
[TBL] [Abstract][Full Text] [Related]
15. Characterization of genetically defined sporadic and hereditary type 1 papillary renal cell carcinoma cell lines.
Yang Y; Ricketts CJ; Vocke CD; Killian JK; Padilla-Nash HM; Lang M; Wei D; Lee YH; Wangsa D; Sourbier C; Meltzer PS; Ried T; Merino MJ; Metwalli AR; Ball MW; Srinivasan R; Linehan WM
Genes Chromosomes Cancer; 2021 Jun; 60(6):434-446. PubMed ID: 33527590
[TBL] [Abstract][Full Text] [Related]
16. [Mechanism of carcinogenesis by germline mutation of protooncogene in hereditary tumors].
Miyaki M
Nihon Rinsho; 2000 Jun; 58(6):1225-30. PubMed ID: 10879045
[TBL] [Abstract][Full Text] [Related]
17. Biological significance of c-met over expression in papillary renal cell carcinoma.
Sweeney P; El-Naggar AK; Lin SH; Pisters LL
J Urol; 2002 Jul; 168(1):51-5. PubMed ID: 12050491
[TBL] [Abstract][Full Text] [Related]
18. Inherited renal carcinomas.
Kawashima A; Young SW; Takahashi N; King BF; Atwell TD
Abdom Radiol (NY); 2016 Jun; 41(6):1066-78. PubMed ID: 27108134
[TBL] [Abstract][Full Text] [Related]
19. Hereditary kidney cancer: unique opportunity for disease-based therapy.
Linehan WM; Pinto PA; Bratslavsky G; Pfaffenroth E; Merino M; Vocke CD; Toro JR; Bottaro D; Neckers L; Schmidt LS; Srinivasan R
Cancer; 2009 May; 115(10 Suppl):2252-61. PubMed ID: 19402075
[TBL] [Abstract][Full Text] [Related]
20. [c-MET Oncogene in Renal Cell Carcinomas].
Erlmeier F; Weichert W; Autenrieth M; Ivanyi P; Hartmann A; Steffens S
Aktuelle Urol; 2016 Dec; 47(6):475-479. PubMed ID: 28006830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
